InsidersTradesSigma
Clover Biopharmaceuticals, Ltd. - B: insider trades · Hong Kong · HKEX
HKEX:clover-biopharmaceuticals-ltd-bHK·HKEXMcap 312M€Healthcare
Discover the full insider trade history of Clover Biopharmaceuticals, Ltd. - B, a listed issuer based in Hong Kong. Shares are listed on HK HK, under the oversight of HKEX. Operating in the Healthcare sector, Clover Biopharmaceuticals, Ltd. - B has recorded 26 insider filings. Market capitalisation: €312.4m. The latest transaction was reported on 24 April 2026 — Sale. Among the most active insiders: Liang Peng. Every trade is accessible without an account.
26
Insider Decl.
0
Thresholds
·
11 ops.
Buy Volume
€429,331
6 ops.
Sell Volume
Financial data
FY ended December 2024 · cache
2.46 €
Income statement
Revenue38.4 M€
Gross profit21.6 M€56% margin
Net income−903.4 M€-2351.5% margin
Balance sheet & cash
Market cap312.4 M€
Total debt89.6 M€
Free Cash Flow−290.1 M€
Last declaration on 24 April 2026
Declarations26 total
Executives●Sale13HKEX
€206,156600,000 shares@ €0.34360.066% mcap48.0% of flow
ShareXHKG
HKEX:DA20260424E00084·
Executives●Sale8HKEX
€101,199300,000 shares@ €0.33730.032% mcap23.6% of flow
ShareXHKG
HKEX:DA20260417E00037·
Executives●Purchase2HKEX
383,000 shares
ShareXHKG
HKEX:DA20260409E00099·
Ideal exit: 28 Dec 2026 (T+270)
Executives●Purchase2HKEX
1,326,875 shares
ShareXHKG
HKEX:DA20260409E00100·
Ideal exit: 28 Dec 2026 (T+270)
Executives●Purchase2HKEX
9,840 shares
ShareXHKG
HKEX:DA20260403E00017·
Ideal exit: 26 Dec 2026 (T+270)
Executives●Purchase2HKEX
340,000 shares
ShareXHKG
HKEX:DA20260401E00056·
Ideal exit: 22 Dec 2026 (T+270)
Executives●Purchase2HKEX
340,000 shares
ShareXHKG
HKEX:DA20260401E00045·
Ideal exit: 22 Dec 2026 (T+270)
Executives●Purchase2HKEX
340,000 shares
ShareXHKG
HKEX:DA20260401E00054·
Ideal exit: 22 Dec 2026 (T+270)
Executives●Purchase2HKEX
6,577,500 shares
ShareXHKG
HKEX:DA20260401E00050·
Ideal exit: 22 Dec 2026 (T+270)
Executives●Purchase2HKEX
1,145,000 shares
ShareXHKG
HKEX:DA20260401E00048·
Ideal exit: 22 Dec 2026 (T+270)
Executives●Purchase2HKEX
340,000 shares
ShareXHKG
HKEX:DA20260401E00058·
Ideal exit: 22 Dec 2026 (T+270)
Executives●Purchase2HKEX
340,000 shares
ShareXHKG
HKEX:DA20260401E00053·
Ideal exit: 22 Dec 2026 (T+270)
Executives●Purchase2HKEX
340,000 shares
ShareXHKG
HKEX:DA20260401E00052·
Ideal exit: 22 Dec 2026 (T+270)
25 of 26 declarations
About Clover Biopharmaceuticals, Ltd. - B
Clover Biopharmaceuticals, Ltd. is a biopharmaceutical company focused on developing vaccines and therapies for infectious diseases. It is listed on the Hong Kong Stock Exchange under the symbol XHKG.